As the CSF of TBE patients contains a large fraction of CCR5-negative T lymphocytes [21,32], other pathways must supplement the chemotactic effect of CCR5 signaling and should be able to compensate for its dysfunction to some degree. The gene discussed is CCR5; the disease is tick-borne encephalitis.